XRP News Today: Ripple Wins Big as Judge Slashes SEC’s $2B Lawsuit Penalty

Category: Finance

The Court significantly reduced the SEC's demand from $2B to $125M, affirming Ripple's position and dismissing allegations of recklessness or fraud. The SEC may appeal the ruling regarding Programmatic Sales of XRP, but the market reacted positively with XRP prices rising modestly.

Keywords: Ripple, SEC, XRP

Source: FX Empire

Update At: 8/8/2024

Related Sources

Uganda's Chemutai settles for silver as Bahrain's Yavi smashes women's 3,000m Steeplechase Olympic gold

Six senior staff positions at the Bank of Uganda are vacant following a recent reshuffle, effective August 6, 2024, after board approval of the new organizational structure.

Daily Monitor

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm

Class actions have been initiated for stockholders of CVS Health, Walgreens, SeaStar Medical, and Bolt Biotherapeutics due to misleading statements regarding their business operations and financial forecasts. CVS faced significant stock price drops following revisions to its earnings guidance and operational income, primarily due to issues in its Health Care Benefits segment. Walgreens and SeaStar also reported financial challenges, leading to class action notices for investors. Bolt Biotherapeutics is accused of overstating the effectiveness of its product pipeline.

Morningstar

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CVS Health Corporation (CVS)

Investors in CVS Health Corporation are reminded of the September 10, 2024 deadline to file a lead plaintiff motion in a class action lawsuit due to significant stock price declines following the company's revised earnings guidance and financial results. The lawsuit alleges that CVS made misleading statements regarding its business operations and financial forecasts, particularly in its Health Care Benefits segment, which led to investor losses.

GlobeNewswire

5 Things to Know Before the Stock Market Opens

Walt Disney Co. reported strong third-quarter results, surpassing revenue and profit expectations, driven by successful box office releases and profitability in its streaming segment. Novo Nordisk shares fell after missing revenue forecasts and cutting its profit outlook due to supply constraints. CVS Health also saw a decline in shares after lowering its earnings guidance amid rising medical costs. Global markets rallied following the Bank of Japan's decision to maintain interest rates amid volatility. Super Micro Computer's shares dropped significantly after disappointing earnings and a light profit forecast.

Investopedia

Disney, CVS Health And 3 Stocks To Watch Heading Into Wednesday - Walt Disney (NYSE:DIS)

U.S. stock futures are trading higher, with key companies like McKesson, Wix.com, and Disney set to report earnings. McKesson is expected to report earnings of $7.21 per share, while Wix.com has raised its outlook after better-than-expected results. Disney is anticipated to post earnings of $1.20 per share. Rivian reported a wider loss, and CVS Health is expected to post earnings of $1.73 per share.

Benzinga

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm

Class actions have been initiated for stockholders of CVS Health Corporation, Walgreens Boots Alliance, SeaStar Medical Holding Corporation, and Bolt Biotherapeutics due to misleading statements regarding their business operations and financial forecasts. CVS faced significant stock price drops following revisions to its earnings guidance and operational income, while Walgreens and SeaStar also reported financial challenges. Bolt Biotherapeutics is accused of overstating the effectiveness of its product pipeline.

GlobeNewswire

Why Are Hedge Funds Bullish on Hilton Worldwide Holdings Inc. (HLT) Now?

Hilton Worldwide Holdings Inc. (NYSE:HLT) is positioned as a leading player in the recovering travel and leisure sector, which is expected to reach pre-pandemic levels by the end of 2024. The company is focusing on digital initiatives, luxury properties, and strategic partnerships to enhance growth. Despite concerns over its premium valuation, Hilton is projected to return $3 billion to shareholders, reflecting strong investor confidence.

Yahoo Finance UK

The Top 3 Travel Stocks to Buy Now: Summer 2024

The travel industry is experiencing significant growth in 2024, driven by the 'revenge travel' trend post-pandemic. Key stocks like Booking Holdings, Airbnb, and Hilton Worldwide are well-positioned to benefit from this surge, showcasing strong revenue growth and attractive valuations. Booking has seen impressive earnings growth, Airbnb continues to lead in peer-to-peer rentals, and Hilton caters to the premium hotel market with efficient operations.

InvestorPlace

BKNG: 3 Travel Stocks Benefiting From Increased Demand

Travel is experiencing a resurgence with record numbers of travelers and lower costs, benefiting companies like Booking Holdings, Airbnb, and Expedia. The travel market is projected to grow significantly, with strong fundamentals supporting these stocks. Booking Holdings reported a 16.9% revenue increase, Airbnb saw a 17.8% rise, and Expedia's revenue grew by 8.4%. All three companies are well-positioned to capitalize on the ongoing travel demand.

StockNews

10 Best Travel and Leisure Stocks to Buy Now

The travel and tourism sector is recovering rapidly post-COVID-19, with international tourism nearing pre-pandemic levels. The World Travel & Tourism Council anticipates record contributions to the global economy in 2024, with significant growth expected in domestic travel markets, particularly in China. The article lists the 10 best travel and leisure stocks to buy now, highlighting companies like Trip.com Group Limited, Delta Air Lines, and Carnival Corporation, which are well-positioned to benefit from the industry's rebound.

Insider Monkey